Andrew I. Koven
General Counsel, KOS PHARMACEUTICALS INC.
Companies
- MetaVia Inc.Board member Jul 19, 2021 to now1
- Kala Pharmaceuticals (United States)Board member Oct 2, 2017 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- MetaVia Inc. MTVA21,339 shares3$26.2K at $1.23Jun 8, 2026
- Kala Pharmaceuticals (United States) KALA16,972 shares4$3.4K at $0.20Jun 15, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 8, 2026Granted 17,186 shares of MetaVia Inc.3
- Jun 30, 2025Granted 28,147 shares of MetaVia Inc.5
- Jun 15, 2025Granted 3,050 shares of Kala Pharmaceuticals (United States)4
- Jun 11, 2024Granted 1,750 shares of Kala Pharmaceuticals (United States)6
- Jun 7, 2024Granted 5,051 shares of MetaVia Inc.7
- Jul 27, 2023Granted 12,500 shares of MetaVia Inc.8
- Jul 27, 2023Granted 87,500 shares of MetaVia Inc.8
- Jun 22, 2023Granted 1,400 shares of Kala Pharmaceuticals (United States)9
- Jun 22, 2023Granted 7,515 shares of Kala Pharmaceuticals (United States)9
- May 31, 2023Granted 2,197 shares of Kala Pharmaceuticals (United States)10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMetaVia Inc., Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jul 1, 2025
- 6SEC EDGARForm 4 filed Jun 12, 2024
- 7SEC EDGARForm 4 filed Jun 7, 2024
- 8SEC EDGARForm 4 filed Jul 28, 2023
- 9SEC EDGARForm 4 filed Jun 23, 2023
- 10SEC EDGARForm 4 filed Jun 2, 2023